Myeloablative busulfan with cyclophosphamide (BuCy) versus busulfan with fludarabine (BuFlu) in myeloid neoplasms

Abstract

Peer reviewed

Renju V. Raj, Lindsay Dozeman, Anna M Button and Margarida De Magalhaes-Silverman

Journal of clinical oncology, Vol.32(15_suppl), pp.7041-7041

05/20/2014

DOI: 10.1200/jco.2014.32.15_suppl.7041

View Online

Title: Subtitle: Myeloablative busulfan with cyclophosphamide (BuCy) versus busulfan with fludarabine (BuFlu) in myeloid neoplasms
Creators: Renju V. Raj - University of Iowa
Lindsay Dozeman - University of Iowa
Anna M Button - University of Iowa
Margarida De Magalhaes-Silverman - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.32(15_suppl), pp.7041-7041
DOI: 10.1200/jco.2014.32.15_suppl.7041
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2014
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984362302102771

2 Record Views